PRFRM 1 | Research library

Evidence, without the overstatement.

A curated reading room for photobiomodulation research - covering recovery, performance, skin and proposed cellular mechanisms. Positive, mixed and null findings belong in the same conversation.

08 Selected papers
05 Controlled human studies
01 Systematic review
02 Laboratory studies

Evidence map

What the literature supports - and where it stops.

Photobiomodulation is not one uniform intervention. Outcomes change with wavelength, irradiance, fluence, treatment area, distance, timing and population. The responsible reading is therefore conditional, not absolute.

Promising

Fatigue recovery

A 2024 meta-analysis reported a pooled benefit for fatigue recovery in healthy people, while finding no support for increased strength or functional capacity.

Mixed

Muscle soreness and markers

Some small controlled trials report favourable changes in soreness, strength loss or biochemical markers. Other controlled work reports no advantage over placebo.

Protocol-specific

Skin appearance

Controlled trials report changes in wrinkle grading, roughness or collagen-related measures under defined regimens. Those findings cannot be transferred automatically between devices.

Active research

Cellular mechanisms

Mitochondrial, redox and nitric-oxide pathways are under investigation. Laboratory results support biological activity, but the primary mechanism is not fully settled.

Protocol, expressed simply

Dose = irradiance × time J/cm² = W/cm² × seconds

This equation describes incident radiant exposure. It does not, by itself, describe how much light reaches or is absorbed by a particular tissue.

Why protocol matters

A wavelength is not a result.

Two products can use nominally similar wavelengths and still deliver materially different exposure. That is why this library records study design and dose context rather than treating “red light” as one interchangeable category.

Wavelength

The spectral band used, commonly reported in nanometres.

Irradiance

Optical power arriving per unit area, commonly mW/cm².

Fluence

Energy delivered per unit area over a session, commonly J/cm².

Geometry and timing

Distance, area, angle, session duration and when exposure occurs.

Selected reading

The studies behind the discussion.

This is a deliberately balanced selection: synthesis-level evidence, controlled human studies with positive and null findings, and laboratory work that tests proposed mechanisms.

Showing all 8 selected papers.

Systematic review Meta-analysis 2024

Functional performance in healthy individuals

Bezerra LO, de Macedo LES, da Silva MLA, et al. Lasers in Medical Science. DOI: 10.1007/s10103-023-03956-2.

DesignSystematic review + meta-analysis
Evidence16 studies / 340 people
Range655–905 nm
What it found

The pooled analysis favoured fatigue recovery. It did not find evidence supporting improvements in maximal strength or functional capacity.

Read carefully

Devices, doses, application sites and treatment timings varied considerably, and the overall participant pool remained modest.

Read on PubMed
Human trial Positive finding 2014

630 nm LED exposure after eccentric exercise

Borges LS, Cerqueira MS, Rocha JAS, et al. Lasers in Medical Science. DOI: 10.1007/s10103-013-1486-z.

DesignRandomised, double-blind, placebo-controlled
Sample17 healthy young men
Protocol630 nm / 20.4 J/cm²
What it found

The active group showed less soreness, strength loss and range-of-motion impairment after a damaging elbow-flexor exercise protocol.

Read carefully

This was a small, male-only study using one muscle group and one tightly specified post-exercise protocol.

Read on PubMed
Human trial Mixed outcomes 2009

830 nm laser before high-intensity exercise

Leal Junior ECP, Lopes-Martins RAB, Baroni BM, et al. Lasers in Medical Science. DOI: 10.1007/s10103-008-0633-4.

DesignRandomised, double-blind crossover
Sample20 male athletes
Protocol830 nm / 3–4 J per point
What it found

Selected CK and lactate outcomes were lower after active exposure, but Wingate work performance did not differ from placebo.

Read carefully

Small athlete subgroups, biochemical surrogate outcomes and a laser point-application protocol limit transfer to large LED panels.

Read on PubMed
Human trial Null finding 2019

660–850 nm PBM after sprint-interval exercise

Malta ES, Lira FS, Machado FA, et al. Frontiers in Physiology. DOI: 10.3389/fphys.2018.01948.

DesignDouble-blind, placebo-controlled
Sample12 men in placebo comparison
Protocol660–850 nm / 600 J total
What it found

The study did not find an advantage over placebo for the measured recovery indicators and did not outperform active recovery or cold-water immersion.

Read carefully

The placebo comparison was small and tested a specific high-total-energy, post-exercise protocol following repeated sprint sessions.

Read on PubMed
Human trial Skin appearance 2014

Red and near-infrared light for skin appearance

Wunsch A, Matuschka K. Photomedicine and Laser Surgery. DOI: 10.1089/pho.2013.3616.

DesignProspective controlled trial
Sample136 volunteers
Spectra611–650 or 570–850 nm
What it found

After 30 sessions, intervention groups showed improvements in several measured skin-appearance and collagen-density outcomes compared with controls.

Read carefully

The sources were polychromatic and unlike PRFRM devices. Treatment was not blinded, controls were recruited differently, and the device manufacturer funded the study.

Read on PubMed
Human trial 630 + 850 nm 2025

Home-use LED/IRED mask for crow’s feet

Park SH, Park SO, Jung JA. Medicine. DOI: 10.1097/MD.0000000000041596.

DesignRandomised, double-blind, sham-controlled
Sample60 participants enrolled
Protocol630 + 850 nm home-use mask
What it found

Independent-rater and investigator crow’s-feet grading favoured the active mask at the reported 8-, 12- and 16-week assessments.

Read carefully

This tested one facial mask, one cosmetic outcome and a defined regimen. It is not evidence of equivalent performance by another device.

Read on PubMed
Laboratory Dose response 2020

Biphasic response in human skin fibroblasts

Flores Luna GL, de Andrade ALM, Brassolatti P, et al. Photobiomodulation, Photomedicine, and Laser Surgery. DOI: 10.1089/photob.2019.4729.

DesignIn-vitro dose comparison
ModelHFF-1 human fibroblasts
Protocol660 nm / multiple fluences
What it found

Lower tested fluences increased mitochondrial activity and cell viability, while higher tested energies reduced responses—consistent with a biphasic pattern.

Read carefully

Cells in culture are not a human clinical outcome. The result supports dose sensitivity, not a treatment claim or a universal optimum dose.

Read on PubMed
Laboratory Counter-evidence 2021

Testing the cytochrome-c-oxidase hypothesis

Quirk BJ, Whelan HT. Photobiomodulation, Photomedicine, and Laser Surgery. DOI: 10.1089/photob.2020.4978.

DesignIsolated-enzyme experiment
TargetCytochrome c oxidase
Protocol670 and 830 nm
What it found

The experiment found no significant change in oxygen-consumption kinetics and no light-driven relief of nitric-oxide-donor inhibition under the tested conditions.

Read carefully

An isolated enzyme system cannot represent the full biology of living tissue, but it cautions against presenting one proposed mechanism as settled fact.

Read on PubMed

Our evidence standard

What this page does not claim.

The value of a research library is not the number of papers it can display. It is the precision with which it describes what those papers can - and cannot - establish.

01Independent research is not PRFRM product validation.

None of the papers above tested a PRFRM 1 product. They provide context for the wider PBM field only.

02Matching wavelengths do not guarantee matching exposure.

Irradiance, fluence, distance, treatment area, timing, optical design and participant characteristics all matter.

03Biomarkers are not the same as lived outcomes.

A change in CK, lactate, cell viability or an imaging score should not be translated into a broader promise than the study measured.

04Null findings belong in the library.

Conflicting results help show where protocols, populations and outcomes remain uncertain.

Reading the research

Straight answers.

Do these studies prove that PRFRM 1 produces the same results?

No. Direct product validation requires testing the actual device, its measured output, its protocol and the intended user group. Studies of other devices provide scientific context, not equivalence.

Why use 630 nm and 850 nm?

Red and near-infrared wavelengths around these bands appear frequently in PBM research, and the exact 630/850 nm combination has been used in some controlled studies. Wavelength selection remains only one part of a complete delivery protocol.

Why do different studies reach different conclusions?

Studies differ in wavelength, irradiance, fluence, device type, treatment timing, anatomical site, participant characteristics, sample size and measured outcome. PBM also shows dose-sensitive behaviour, so “more” is not automatically “better”.

Is this a complete systematic review of PBM?

No. This is a curated reading library designed to show representative evidence and important limitations. It should not be treated as an exhaustive review or clinical guideline.

Is this medical advice?

No. This page is educational and does not diagnose, treat or recommend a course of care. Follow the product instructions and seek qualified professional advice for individual medical questions.

Build your setup

Research-informed light. Designed for real routines.

Explore the PRFRM 1 range, compare formats and choose the coverage that fits your space and routine.

Evidence reviewed 5 August 2026 · PRFRM 1 products are wellness devices and are not intended to diagnose, treat, cure or prevent disease. References describe independent research and do not establish product-specific clinical performance.

Study details